Long-term persistence of antibodies after one or two doses of MMR-vaccine

Vaccine. 2007 Sep 17;25(37-38):6672-6. doi: 10.1016/j.vaccine.2007.07.008. Epub 2007 Jul 26.

Abstract

Outbreaks of measles, mumps and rubella have occurred recently despite long-standing mass immunization with MMR. Antibody titres for measles, mumps and rubella of 160 students (17-23 years) with proof of at least one MMR-vaccine were studied according to the number of MMR-vaccines received. The proportion of subjects with positive antibody titres was significantly higher in those who received two vaccines against measles (77.1% versus 58.7%, p=0.05), mumps (67.5% versus 55.6%, p=0.009) and rubella (99.2% versus 71.4%, p=0.008). Comparable significant trends were seen for GMTs for measles and mumps. A similar non-significant trend was noted for rubella.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology*
  • Dose-Response Relationship, Immunologic*
  • Female
  • Humans
  • Male
  • Measles-Mumps-Rubella Vaccine / administration & dosage*
  • Measles-Mumps-Rubella Vaccine / immunology*
  • Time Factors

Substances

  • Antibodies, Viral
  • Measles-Mumps-Rubella Vaccine